Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA – Streetwise Reports
|
Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA
Streetwise Reports Immunotherapy Firm Gets Green Light for Pivotal Trial From FDA Research Report. Source: Streetwise Reports (12/27/17). Jason Kolbert, an analyst with Maxim Group, described the study, which enables this biotech's device to be used in patients … |
